Archive for ADHD Medication

How To Tell The Difference Between Concerta and Generic Concerta

In Canada, there is a generic Concerta available. It’s called: Teva-Methylphenidate ER-C (it was formerly called: Novo-Methylphenidate ER-C). Many people have had trouble with this generic, and it is widely accepted by doctors in Canada and patients that the generic doesn’t work as well as the brand name concerta.

One question which has been sent in to me a number of times is: How do I tell the difference between the brand name Concerta and the generic Teva-Methylphenidate ER-C?

When someone isn’t medically trained, it can be very confusing. I have tried to explain to people over the phone (or in blog comments!) how to tell the difference. And then I thought of the saying: “A picture is worth 1,000 words”. I was able to find an image which clearly shows the difference between the two medications. I was able to get permission from Janssen (the maker of Concerta) to share this image with you.

To tell the difference between the brand Concerta compared to the generic, notice a few features:

  • The brand Concerta has the word ‘Alza’ typed in black on its side; the Generic Teva MPH ER-C does not have this typed word on it
  • The brand Concerta looks more rounded like a little soda can, compared to the generic which is an oval pill
genericconcertacanada 801x1024 How To Tell The Difference Between Concerta and Generic Concerta

Generic Concerta vs. Brand Name Concerta in Canada

Please share any comments below. And feel free to share this with anyone who may benefit from knowing about this.


Dr. Kenny

Technorati Tags: , ,

ADHD Medication Free Webinar Training

At the end of March 2012, I did a webinar training for ADD, called “ADHD Medication Update”.

I’m sharing the video here, and it’s broken into 4 different video segments:

1) Introduction – this is the introduction, and let’s you know what I’ll cover during the training.

2) This is the main teaching – during this session, I cover WHY we use ADHD medications, and help you to understand that there are really only 4 types of ADHD medication – a) methylphenidate medicines, b) amphetamine medications, c) non-stimulant atomoxetine, d) non stimulant guanfacine.

We’ll cover how to make decisions around changing or adjusting medication, as well as a discussion about tolerance to ADHD medication

3) In the third video, I share some information on the ADHD Medication Shortage in the US, and strategies you can use to help yourself during this struggle.

4) In the fourth and final video, I share a summary of the ‘Ritalin Gone Wrong’ article, and share some responses to that.

I hope you enjoy the videos. Please feel free to pass them along, and type any comments in below.

Dr. Kenny

Technorati Tags: , , ,

Ritalin Gone Wrong Response

A recent article in the New York Times entitled: “Ritalin Gone Wrong” was very critical of the current treatment for ADD/ADHD. There are significant problems with the arguments forwarded in the article. I was interviewed on the News about this issue, on Thursday February 2nd, 2012. Here’s the video. I will write a more detailed response on this blog for your shortly.

To start the video, just click the button below:

For iPhone/iPad video, click here.

Please feel free to share this video with others who may want to know this information, and please share your thoughts and comments below.


Dr. Kenny

Technorati Tags: ,

Vyvanse Now Covered on Ontario Drug Plan

Vyvanse (lisdexamfetamine) is one of the newer medications for ADHD. It has been in Canada since February 2010. However, the provincial insurance plans did not cover it.

I’m pleased to announce that as of June 8, 2011, Vyvanse will be covered by the Ontario Drug Plan. This means that if a family has an Ontario drug card (from being on OW, or ODSP, or a child disability, or even the Trillium Drug Plan), then Vyvanse will be covered.

The rules for Vyvanse coverage are written as follows:

Notes: Patients > 6 years of age diagnosed with ADHD according to DSM-IV criteria and where symptoms are not due to
other medical conditions which affect concentration, and who require 12-hour continuous coverage due to academic and/or
psychosocial needs, and who meet the following:
1) Patients who demonstrate significant and problematic disruptive behaviour or who have problems with
inattention that interfere with learning; AND
2) Prescribed by or in consultation with a specialist in pediatric psychiatry, pediatrics or a general practitioner
with expertise in ADHD; AND
3) Have been tried on methylphenidate immediate release (IR) or methylphenidate slow release (SR) or
Dexedrine IR or Dexedrine SR (Spansules), and have experienced unsatisfactory results due to poor
symptom control, side effects, administrative barriers, or societal barriers.
Administrative barriers include:
. inability of a school to dose the child at lunch;
. the school lunch hour does not coincide with the dosing schedule;
. poor compliance with noon or afternoon doses;
. the patient is unable to swallow tablets.
Societal barriers include:
. the patient or patient’s caregiver(s) has(have) a history of substance abuse or diversion of listed
immediate-release alternatives;
. the patient or patient’s caregiver(s) is/are at risk of substance abuse or diversion of listed
immediate-release alternatives.

From a practical perspective, the doctor does not have to complete a form, or get formal approval, so it will be up to your doctor to decide when he or she will begin using Vyvanse with you.

This is very good news for ADHD patients in Ontario. I know that a lot of advocacy work went on, spearheaded by CADDAC. I know that I spoke to my MPP and got him to write a letter of support, and many other doctors and patients did the same. I hope that this precedent will help to get coverage in the other provinces too.


Dr. Kenny

Technorati Tags: ,

Death From ADHD Medication?

A recent study was published in the Journal: Pediatrics, which shows that there is not an increase in cardiovascular death when kids or teens take ADD/ADHD medications.

This was a large study – observing 214,417 ADHD patients taking medication, and 965,668 control kids – not taking ADHD medications. They were observed over a period of 135 days for ADHD medication users, and 609 days in non-users. The specific outcomes which were being observed included sudden cardiac death, myocardial infarction (a ‘heart attack’), stroke, and cardiac arrhythmias (i.e. irregular heartbeats).

During the observational period – the rate of these events were very low in both groups.

In the group taking ADHD medication, there were 28 deaths (incidence 1.79 per 10,000 person-years) and 607 deaths in the control group (incidence 3.00 per 10,000 person-years). There were no validated cases of MI (heart attack) or stroke in the medication group and 11 cases in the group which wasn’t on medication.

This research supports previous studies which showed that kids and teens taking ADHD medications are not at increased risk for cardiac death. The sad reality is that there will be a small number of kids/teens who pass away from cardiac issues (i.e. a heart problem that no one knew about), and ADHD medications don’t seem to worsen that rate.

There is still a warning on ADHD medications – for individuals with structural heart abnormalities (i.e. ‘holes’ in the heart like an ASD or VSD), arrhythmias, or adults with unstable coronary artery disease. If you are concerned about this – by all means talk to the doctor, and a specialist if needed as well (like a cardiologist, or pediatric cardiologist).

Hopefully this study helps to reassure some people with ADD/ADHD who are concerned about this very serious side effect.


Dr. Kenny

p.s. this study applies to ALL ADHD medications – including: Adderall, Vyvanse, Concerta, Ritalin, Metadate, Biphentin, Strattera, Daytrana, etc.

Technorati Tags: , ,

Generic Concerta in the US

Article updated on May 11, 2011:

A recent new report shows that Watson Pharmaceuticals is cleared to create a generic form of Concerta for the US. A recent court of appeal decision is reported to have said that the patent on Concerta is invalid and that Watson is cleared to make their own version of the drug. Johnson and Johnson, the parent company which makes Concerta, had worldwide sales of $1.33 billion of Concerta last year.


According to this report, Watson is now authorized to sell a generic version of Concerta. This report shares the fact that the sales of Concerta totaled $1.5 billion in the year ending Feb 28, 2011 (it is unclear if that is worldwide or US data).

The report says:

Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceutical unit is making and supplying the drug, and it will receive a share of the revenue from sales. Watson will market and distribute the generic.

The agreement lasts until the end of 2014. Watson can launch its own generic version when the deal ends.

What does this mean for you?

If you take Concerta (and you are in the USA), then it appears that you will be able to get a generic version of the drug which is sold by Watson, and manufactured by Ortho-McNeil. In other words – this should be the exact same medicine. This will last until 2014 – at which time this deal ends, and Watson will be creating its own version of generic Concerta.

This is quite a different circumstance than what is going on in Canada.
My experience in Canada is that the new generic Concerta which has surfaced in Canada is quite an inferior drug, and falls short of Concerta in many ways. That didn’t stop Health Canada from approving the medicine, and deeming it interchangeable – which allows pharmacists to automatically substitute the medicine to people, even if they come in with a prescription requesting Concerta. To read more about this, please refer to my article on Generic Concerta in Canada.

As always – the power of this blog comes from the discussion -and from you sharing your experiences and providing real feedback as to what is going on. As your prescription shifts from the ‘brand name’ Concerta to the Generic Concerta (from Watson), please take a moment and let us know if it is working well and if it seems the same to you.


Dr. Kenny

Technorati Tags: , , , , , ,

Vyvanse in Canada

Updated January 3, 2011:

Vyvanse was officially launched in Canada on February 1, 2010.
When it was first launched – it was only officially approved for use in children – aged 6-12 years old. As of November 2010, Vyvanse is now officially indicated for use in ADHD in children (6-12 years old), teenagers (13-18 years old), and adults (18-65 years old). This means that Vyvanse is now officially indicated in Canada for use in ADHD ‘across the lifespan’ – i.e. from childhood to adulthood.

Dosage of Vyvanse in Canada:
Vyvanse is available in these dosage strengths in Canada: 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg.
In the US, there is also a 70 mg capsule – but Health Canada wasn’t convinced that it was needed – so for now, the highest dose capsule that we have in Canada is the 60 mg.

Doctors will generally start with a lower dose (often 30 mg) and then increase to a higher dose (often 50 mg). Of course, your doctor will tailor the treatment to your needs.

Vyvanse is a the first prodrug for ADHD. This means that the medication is inactive until an enzyme in the body works to activate it. To read more about how it works, visit this blog post on Vyvanse.

To read the press release on Vyvanse being released in Canada, please view it here.

This blog has several articles on Vyvanse, but my favorite is the one where my readers have shared their experiences with Vyvanse (over 800 comments at this time) about whether Vyvanse works.
You can find more articles by looking at the ‘related posts’ below this article.

Please share any comments or issues with Vyvanse being in Canada below.


Dr. Kenny

Technorati Tags: , , ,

Vyvanse for Teenagers

Vyvanse is a prodrug stimulant medicine which was initially launched in the US for children (6-12 years old) with ADHD, and then later approved for adults (18-65 years old) with ADHD.

As of November 2010, Vyvanse has been approved for use in teens as well – in the USA.

This means that Vyvanse is now officially approved for individuals with ADD/ADHD from the ages of 6 years old to 65 years old.

In Canada, Vyvanse was initially approved for children with ADHD only – and in November 2010, the approval was achieved with Health Canada for teenagers as well (and adults too!).

What does it mean now that Vyvanse is approved for Teenagers?

While most ADHD experts were comfortable to use this medication with teens even before the official approval, there are more doctors who will feel comfortable to use it now that it is officially approved. So, if your teens sees a general pediatrician, your doctor may feel more comfortable to use Vyvanse now that it is officially approved in this age range.

It can also impact insurance coverage:
There was a teen in my office whose private insurance coverage would not cover Vyvanse because of the fact that it was not officially indicated (approved) for teens. Now that it is approved, he can get insurance coverage for his prescription.

Here is a summary of research which was presented at the American Psychiatric Association Meeting which documents that Vyvanse is effective and safe for teenagers. You can read details of the study here.

Please share your experiences of how the official approval of Vyvanse in teens may affect your teen’s ADHD treatment.


Dr. Kenny

Technorati Tags:

ADHD Medication and Co-Existing Conditions

Virtual AD/HD Conference

 ADHD Medication and Co Existing Conditions

When it comes to ADD/ADHD, it is relatively rare that people just have the one condition. It is very common that people have 2 or even 3 conditions.

What else comes with ADD/ADHD?
It is very common for people to have the following conditions in addition to ADD/ADHD:

  • Depression
  • Anxiety
  • Behavior Disorders
  • Learning Disabilities
  • Tic disorders
  • and more…

When doctors are prescribing medication for ADD/ADHD, they may not account for the co-existing condition. Sometimes, the ADD/ADHD medication may impact on the other condition, or vice-versa – i.e. the medication for the other condition (i.e. anxiety) impacts the ADD/ADHD. It is important to understand the nature of this relationship.

This post contains the audio from an interview that I did with Jennifer Koretsky for the Virtual ADHD Conference 2010. In it, I share some facts about ADD/ADHD and co-existing conditions. And, I also encourage you to join us for the conference – where I will spend an hour teaching on this concept, and there will be a lot of other ADD/ADHD experts to help you to find answers to your biggest issues, and learn more about many aspects of this challenging condition. The Virtual ADHD Conference is on October 4, 5 and 6 2010.

Here’s the interview: ADHD Medication and Co-existing Conditions By: Dr. Kenny Handelman

Please note – in standard medical terminology – the term for this is: Comorbidity. In other words, a doctor may say: “he has ADHD and comorbid Depression”. It’s my feeling that people with ADD/ADHD have to deal with so much negativity a lot of the time, that I generally use the term: Co-existing rather than comorbid. Just my preference icon smile ADHD Medication and Co Existing Conditions

A Bribe To Consider Joining the ADHD Virtual Conference:
Is it wrong to bribe you to consider joining the ADHD Virtual Conference?
From my perspective, if you are considering joining, I want to give you a bonus – or a reason why to join today. If you feel that the conference isn’t for you, then this ‘bribe’ won’t impact you, and you won’t mind anyway, right?

To help to motivate you – especially since it is August – I’ll give a bonus to anyone who signs up before the end of August 2010. So – to qualify for the bonus, you’ll need to sign up before midnight on August 31, 2010.

What will the bonus be?
I’ve been thinking about what I can do to help you after the ADHD Virtual Conference. This conference will host a lot of great ADHD experts, and you may be inundated with information.
What you may need, after a conference like this, is the opportunity to ask questions about how to personalize the information to suit your personal situation or circumstances.
To help you with that – if you sign up from this blog (or my email list), I will host a question and answer call. I anticipate this will be a small group call, which will allow you to ask your questions of me directly. And different than many of the other question and answer calls I’ve done in the past, this one will be with an ‘open telephone line’. That will allow you to talk directly with me, and we can explore your issues in a discussion.
The date for the call will be chosen in early October. It will be one weeknight (i.e. Monday through Thursday) at 9 pm eastern time. There will only be one time and date for the call. If you can’t attend the call live, you can forward detailed question(s), which I’ll answer and you can listen to the recording. And if you attend live, I’ll chat directly with you.
The call will go for approximately 1 hour (or less or more depending on how many questions there are).
How many people will be on this call? If past experience is a measure, it will likely be a small group. This is a great opportunity for you to have a discussion with me, so that I can bring all of my experience and knowledge of ADD/ADHD to help you out in a small, personal setting.

Here’s what to do now:
If you feel like the ADHD Virtual Conference would be of benefit to you, and you’d like the opportunity to have a small group question and answer call with me (to discuss your personal questions or situation), then follow these steps:

  1. Visit the ADHD Virtual Conference website and register for it
  2. Forward your receipt email to our email support team:
  3. Wait for the announcement of the special, exclusive Q and A call with Dr. Kenny Handelman. You’ll find out the date in early October 2010, and the call will be in late October 2010, on a weeknight, 9 pm Eastern time. There will only be one option available for the Q and A call, and you can attend live for an ‘open telephone’ conference call to ask your questions, or submit your questions via email to get answers and help for your specific situation.

As a disclaimer, our company receives a small referral fee for sending you to the virtual conference through our link. However, we are encouraging you to participate because we believe that you’ll get great value out of the virtual conference, if you decide to participate.

I hope you’ll join me for the ADHD Virtual Conference!


Dr. Kenny

p.s. remember – this bonus is only valid for sales which are made before August 31st, 2010 at midnight.
p.p.s. if you’ve already purchased this conference through my blog or email list, you get this bonus already :-). You just need to forward us the email receipt so that we can put you on the ‘bonus list’

Virtual AD/HD Conference

Technorati Tags: , ,

Generic Concerta in Canada

*This article has been updated on May 30, 2010.

Concerta is a long acting preparation of Methylphenidate. It was launched in the US in 2000, and in Canada in 2003.

When a new medication is released, the company which produces it has a patent for a certain number of years. This allows them to market the medication exclusively until the patent runs out. This is important for the company to recoup the money invested in research and development of the new medicine, as well as to earn a profit.

I understand that it is reasonably regular that the generic pharmaceutical companies petition the courts to create a generic version of the medication BEFORE the patent runs out. Companies that create generic medicines are able to take the formula of the medication, and produce it. They then sell it at a lower price than the original medication. Often times, the generic is at a price point that is only 20-30% better than the original medication.

For background on generic medication, I want to point you to these resources:

Concerta Going Generic In Canada:

Concerta was brought to market in Canada by Janssen Ortho. In mid January 2010, Novopharm won a lawsuit in Canada, to be able to start to produce a ‘concerta like’ medication in Canada. The courts essentially overthrew Janssen’s patent on Concerta. Novopharm is planning to market Novo-Methylphenidate ER C, as a replacement for patients taking Concerta.

N.B. In early summer 2010, the name of the generic medicine will change from: Novo-Methylphenidate ER-C to Teva-Methylphenidate ER-C. This article will be updated when the product’s name is fully changed over.

Let’s Review the Pros and Cons of Novo-Methylphenidate ER-C:

Cons of Generic Concerta:

1) Does this medication work equally to Concerta?

Unfortunately, no one knows the answer to that. For a generic company to get approval for a new medication, they simply have to prove that their medication is absorbed within the range of 80% – 125% of the original compound. That is a huge variance.

The problem with that range? This means that the original Ritalin SR could likely meet criteria to be a generic for Concerta.

If you’ve been around long enough to remember Ritalin SR (or if you have not had insurance so it was the most cost effective medication option), you’ll know that Ritalin SR was widely found to be a very ineffective long acting medication. It often did not last longer than short acting methylphenidate in most of my patients. Most of the doctors in the field considered adding Concerta to the medications available in Canada to be a huge improvement, because we could get away from Ritalin SR and its poor efficacy.

I have been unable to get any scientific data (and neither have any of my colleagues) to demonstrate how Novo-Methylphenidate ER-C works. For all we know, it could work like Ritalin SR – which essentially means that it won’t work very well at all.

Concerta has a lot of technology in each little pill. Each pill has a laser drilled hole in it. There is short acting Methylphenidate on the outside of the pill, and then there is an osmotic capsule (meaning that water can come into the capsule from the gut). The water from the gut comes into the capsule, and expands a polymer, which then pushes the medication out of the pre-drilled laser hole – in a researched process which delivers the medication in a fashion which has been shown to work best for people.

Has Novopharm invested what is needed to develop this complex a medication delivery system?
No – they haven’t.

2) Will you be able to control which medication you get?

Let’s say a member of your family is doing very well with Concerta as a treatment for their ADHD. Now that there is a generic product – can you guarantee that you can keep this product as your monthly medication?

Not necessarily.

As of late April 2010, the Ontario government has deemed Novomethylphenidate ER-C interchangeable with Concerta.

When a medicine is deemed interchangeable, then pharmacists have an obligation to automatically substitute the generic form of the medicine for the brand name version. in other words, your pharmacist will have to substitute your Concerta with Novo-methylphenidate ER -C.

There are a couple of factors which can impact whether you get Concerta or the Generic:

  • Your insurance: your third party medication insurance may decide that to save cost, they insist that you take the generic Concerta, and they may not cover the real Concerta. If the generic doesn’t work for you, you may have to either pay for it out of pocket, or just stick with the generic.
  • If you are on a government provincial drug plan – they may insist on the generic version, and not cover the name brand Concerta any more (Ontario has just forced automatic substitution on their plan).
  • What your pharmacy carries: some pharmacies may order in ONLY the generic version, and stop carrying the name brand Concerta. In this case, you may have to go to another pharmacy to get the medication you need.
  • How your doctor writes the prescription: If your doctor just writes the prescription for ‘Concerta’, the pharmacy can substitute it automatically for the generic. If your doctor writes the words: NO SUBSTITUTION on the prescription, then the pharmacy will have to give you the name brand Concerta.

Pros of Generic Concerta:

  • If this generic works well, then this means there will be a lower cost long acting medication option for people who can’t afford the more costly brand name Concerta. It seems that the price reduction is in the range of 50%.

Overall, as you might have gathered, I feel very uncomfortable with the Generic Concerta at this time (Novo-Methylphenidate ER-C). Most people that I see in my office have had a long and/or challenging road to get to the diagnosis and treatment of ADHD. Often taking a medication for ADHD is a huge decision, and arriving at a medication which works well with few side effects is beneficial and often a relief for concerned parents and family. To have that medication changed and become less effective would be very detrimental to my patients – and create a huge disruption to their lives.

Will Novo-Methylphenidate ER-C work well?

I don’t think anyone knows right now. Where is the scientific data?

I don’t know anyone who has seen it yet. And despite this, pharmacies across Canada can start stocking this and replacing it for regular Concerta (and they don’t even have to get your permission).

What do I recommend you do if you or a family member take Concerta?

  • Ask your doctor to write a prescription for Concerta NO SUBSTITUTION (it doesn’t have to be capitalized – I am adding that for emphasis). Your doctor can even write: No Sub (which is faster!). It has to be in handwriting. If it is a stamp, or some other form of automated process, then the pharmacist can ignore it.
  • Talk to your pharmacist about this – to check if you can still get the name brand medication
  • Look closely at your prescription bottle – to see if the medication is: Concerta, or ‘Novo-Methylphenidate ER-C’
  • If needed, check with your third party insurance for medication – to see if you are still able to get the name brand Concerta covered
  • If you start to notice that Concerta isn’t working as well as it used to – look closely at the bottle, and realize that your prescription may have been substituted for the generic.

As this is a significant change to medication for ADHD in Canada, and one which came as a surprise – I wanted to provide you with some background. I’ll be happy to update this blog as more information comes out, and I know more about this.

One of the things that has been very helpful to many people on this blog – is that readers like you share their stories in the comments below (as you saw with the link about Adderall XR going generic in the US). So, I ask you to share your thoughts, experiences and comments below. Let’s help one another figure out how this new medication works, as well as what is going on in pharmacies, and with insurance coverage, etc. Thanks in advance for your contribution to this post.

New Updates:

Janssen Ortho Releases A Program To Help To Keep You on Brand Name Concerta:

Janssen Ortho is the company making Concerta. They have invested a lot of resources into developing Concerta, as well as educating doctors, educators, and patients and their families about ADHD and its potential impact on people’s lives.

The acceptance of the generic medicine as ‘interchangeable’ is leading to people being taken off of Concerta and being put on the generic very quickly.

Janssen has created a program which can help you to stay on the brand name product. It is called the: “Concerta Co-Pay Assist Program”.

What happens is this:

  1. You get a prescription from your doctor that says: Concerta No Substitution
  2. You go to the pharmacy, and give in the prescription – and insist that you get the brand name product.
  3. If the pharmacy says that your insurance will only cover the generic product, and you have to pay the difference – then you give the pharmacy a ‘Concerta Co-Pay Assist Card, and then Janssen Ortho will pay the difference between the generic medicine and the brand name medicine.

In other words, when you give one of these cards to the pharmacist – you won’t have to pay any extra above the costs of the generic medicine. This applies whether you are on the Ontario Drug Benefit Card, or whether you are on private insurance (i.e. from your work), or even if you are a cash payer.

Here is an image of the card:

ConcertaCoPayAssistCard Generic Concerta in Canada

You’ll notice that the card says: ‘Multi Use Patient Co-Pay Assist Program’.

This means that you can use the card over and over again, as long as you are taking Concerta (and as long as Janssen continues to run the program – which seems to be for the duration at this time). Logistically, you can either leave the card at your pharmacy, or take it with you – just make sure you still have it when you need to refill your prescription.

Now the big question you may have is: where do you get these cards?

These cards are being give out to doctors, as well as to pharmacies. So, ask your doctor if he or she has a card for you. If he or she doesn’t, you can either ask at your pharmacy, or ask your doctor to contact his or her representative from Janssen Ortho to get a card for you.

Hopefully, it will be easy for you to get a card to continue on the brand name Concerta.

***Please note – that at this time – these cards are only available in the following provinces: British  Columbia, New Brunswick, Newfoundland, Nova Scotia, and Ontario,.

Another Update: Potential For Abuse:

One of the risks with Methylphenidate medicines is that the medicines can be abused. Kids in school yards can sell ritalin (or short acting methylphenidate medicines) for $5 per pill. Many people will take the tablet – and crush it, so that they may snort it. When they change the route of delivery to the brain (i.e. when the medicine is absorbed via the nose vs. via the stomach), it can increase the speed of the medicine getting to the brain and it can then increase the abuse potential – i.e. people can get a ‘high’ from it when they snort it.

Concerta has a polymer inside, and a hard outer capsule. When it is crushed, there is no powder which can be snorted.
However, the Novo-methylphenidate ER-C can be crushed easily.

Look at the picture below which shows two 54 mg capsules – Novo-Methylphenidate ER C on the left, and Concerta on the right.

Generic Concerta Canada Generic Concerta in Canada

Generic Concerta versus NovoMethylphenidate ER C

You can clearly see that the Generic medicine is easily crushed into a powder which could increase the chances of the medicine being abused.
There are studies done which show that with Concerta, there is less risk of abuse. There aren’t any studies done on Novomethylphenidate ER C yet, but, as they say – a picture is worth a thousand words. This picture shows that it can be crushed into a fine powder – thus increasing the risk of abuse.


Dr. Kenny

p.s. regarding dosing – Novo-Methylphenidate ER-C will be available in the same doses as Concerta:

  • Novo-Methylphenidate ER-C 18 mg
  • Novo-Methylphenidate ER-C 27 mg
  • Novo-Methylphenidate ER-C 36 mg
  • Novo-Methylphenidate ER-C 54 mg

p.p.s. A comment from me about this blog post: I am not being reimbursed by Janssen Ortho for this blog post. I do not own any of their stocks. I use this blog to post my opinions and to share updates to science, research and general ‘goings on’ in the field of ADHD. That is what is happening here. I happen to feel very strongly about the generic Concerta not working as well as the brand name product – and that is why I am working hard in my office to support people staying on the product, and using this blog to get the information out to a broader audience as well.

Technorati Tags: , , , , ,